Health Care·Pharmaceuticals·$49.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.79 | N/A | -2.11% |
management commentary, guidance changes, and full analysis available with Pro.
| -2.11% |
Tone: Cautiously Optimistic
Management remains positive about the future, emphasizing strong demand in their core business. However, they acknowledged some short-term pressures.
Management highlighted ongoing demand for animal health products.
They expressed confidence in long-term growth despite current challenges.
The earnings report shows that while Zoetis missed EPS expectations slightly, the stock reacted positively, increasing by 5.68%. This suggests that investors are encouraged by management's confidence in long-term growth and demand for their products, despite the EPS miss. The lack of guidance may leave some investors cautious, but the stock's rise indicates optimism in the company's future prospects.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
STERIS PLC
Feb 11, 2019